Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Becton, Dickinson and Company

Market Cap 40.3B 34.84B 32.09B 30.06B 56.37B 3,832B 57.21B 380B 148B 1,864B 151B 148B 6,455B P/E Ratio 2026 *
36.4x
P/E Ratio 2027 * 28.1x
Enterprise Value 56.25B 48.63B 44.8B 41.96B 78.69B 5,349B 79.87B 531B 207B 2,602B 211B 207B 9,010B EV / Sales 2026 *
2.93x
EV / Sales 2027 * 2.76x
Free-Float
74.04%
Yield 2026 *
2.63%
Yield 2027 * 2.68%
1 day-0.75%
1 week-3.25%
Current month-0.60%
1 month-0.86%
3 months-8.39%
6 months-27.20%
Current year-24.65%
1 week 144.4
Extreme 144.4
152.55
1 month 141.82
Extreme 141.8201
153.24
Current year 141.82
Extreme 141.8201
213.08
1 year 141.82
Extreme 141.8201
213.08
3 years 141.82
Extreme 141.8201
287.32
5 years 141.82
Extreme 141.8201
287.32
10 years 141.82
Extreme 141.8201
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer - 29/11/2021
Director TitleAgeSince
Director/Board Member 65 26/03/2025
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Date Insider Type Main position Quantity % Market Cap.
06-10Sell

Executive/Senior Manager

-1,100 0.0004%
06-01Free

Executive/Senior Manager

14,258 0.0052%
06-01Other

Executive/Senior Manager

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-3.25%-16.18%-41.67% 40.3B
-1.64%-3.17%-35.38%-13.04% 154B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.8B
+3.00%+0.30%+55.27%+51.53% 55.22B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-9.03%-40.61% 29.08B
-0.46%+4.55%+46.20%-7.99% 23.23B
-2.85%-3.53%-16.97%-1.50% 20.25B
+0.16%-2.26%-14.38%-0.16% 20.23B
Average -0.39%+0.69%-0.48%-0.13% 53.06B
Weighted average by Cap. -0.44%-0.39%-8.14%+0.79%

Financials

2026 *2027 *
Net sales 19.21B 16.6B 15.3B 14.33B 26.87B 1,826B 27.27B 181B 70.52B 888B 72.07B 70.54B 3,076B 19.71B 17.04B 15.7B 14.7B 27.57B 1,874B 27.99B 186B 72.38B 912B 73.97B 72.39B 3,157B
Net income 1.12B 972M 896M 839M 1.57B 107B 1.6B 10.61B 4.13B 52.02B 4.22B 4.13B 180B 1.45B 1.25B 1.15B 1.08B 2.03B 138B 2.06B 13.68B 5.32B 67.04B 5.44B 5.32B 232B
Net Debt 15.95B 13.79B 12.71B 11.9B 22.32B 1,517B 22.65B 151B 58.59B 738B 59.88B 58.6B 2,556B 14.07B 12.17B 11.21B 10.5B 19.69B 1,338B 19.98B 133B 51.67B 651B 52.81B 51.68B 2,254B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
12/06/26 146.24 $ -0.75% 1,966,917
11/06/26 147.35 $ -0.30% 1,639,985
10/06/26 147.79 $ -2.80% 1,747,951
09/06/26 152.04 $ +1.37% 2,214,895
08/06/26 149.99 $ -0.77% 1,925,969
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
146.24USD
Average target price
180.69USD
Spread / Average Target
+23.56%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!